These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 19356470

  • 1. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Takarada S, Tanaka A, Nakamura N, Mizukoshi M, Tomobuchi Y, Akasaka T.
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [Abstract] [Full Text] [Related]

  • 2. Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?
    Finn AV, Nakazawa G, Ladich E, Kolodgie FD, Virmani R.
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):485-8. PubMed ID: 19356471
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y.
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [Abstract] [Full Text] [Related]

  • 4. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 5. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.
    Kim JS, Kim JS, Kim TH, Fan C, Lee JM, Kim W, Ko YG, Choi D, Hong MK, Jang Y.
    Circ J; 2010 Feb; 74(2):320-6. PubMed ID: 20019414
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y.
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [Abstract] [Full Text] [Related]

  • 7. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L, Baumgartner S, Garcia-Garcia HM, Kalesan B, Justiz J, Pilgrim T, Moschovitis A, Khattab AA, Buellesfeld L, Wenaweser P, Meier B, Serruys PW, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [Abstract] [Full Text] [Related]

  • 8. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T, Kakuta T, Yonetsu T, Takahashi K, Yamamoto G, Iesaka Y, Fujiwara H, Isobe M.
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [Abstract] [Full Text] [Related]

  • 9. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, Yoshino M, Miyake K, Eguchi H, Ohashi N, Hayakawa Y, Saito N, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Imai M, Tanaka H, Fuku Y, Oka N, Kato H, Yamamoto H, Fujii S, Goto T, Mitsudo K.
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [Abstract] [Full Text] [Related]

  • 10. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T, Sawada T, Shinke T, Yamada S, Okamoto H, Kim SS, Takarada A, Yasaka Y.
    Int J Cardiol; 2014 Feb 01; 171(2):224-30. PubMed ID: 24388538
    [Abstract] [Full Text] [Related]

  • 11. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.
    JACC Cardiovasc Interv; 2013 Oct 01; 6(10):1035-45. PubMed ID: 24156964
    [Abstract] [Full Text] [Related]

  • 12. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
    Tanaka N, Terashima M, Rathore S, Itoh T, Habara M, Nasu K, Kimura M, Itoh T, Kinoshita Y, Ehara M, Tsuchikane E, Asakura K, Asakura Y, Katoh O, Suzuki T.
    JACC Cardiovasc Interv; 2010 Oct 01; 3(10):1074-9. PubMed ID: 20965467
    [Abstract] [Full Text] [Related]

  • 13. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E.
    JACC Cardiovasc Interv; 2009 May 01; 2(5):445-52. PubMed ID: 19463469
    [Abstract] [Full Text] [Related]

  • 14. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.
    Choi HH, Kim JS, Yoon DH, Hong KS, Kim TH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Int J Cardiovasc Imaging; 2012 Mar 01; 28(3):491-7. PubMed ID: 21442265
    [Abstract] [Full Text] [Related]

  • 15. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S, Nishino M, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.
    Catheter Cardiovasc Interv; 2013 Apr 01; 81(5):776-81. PubMed ID: 22517601
    [Abstract] [Full Text] [Related]

  • 16. Sex difference in long-term clinical outcome after sirolimus-eluting stent implantation.
    Trabattoni D, Fabbiocchi F, Galli S, Montorsi P, Lualdi A, Grancini L, Ravagnani P, Bartorelli AL.
    Coron Artery Dis; 2011 Apr 01; 22(6):442-6. PubMed ID: 21597366
    [Abstract] [Full Text] [Related]

  • 17. [Characterization of atherosclerotic plaque in patients with unstable angina pectoris and stable angina pectoris by optical coherence tomography].
    Chen BX, Ma FY, Luo W, Ruan JH, Zhao XZ, Xie WL, Sun SH, Guo XM, Wang F, Tian T, Chu XW.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May 01; 37(5):422-5. PubMed ID: 19781218
    [Abstract] [Full Text] [Related]

  • 18. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M, Shimohama T, Tojo T, Shiono T, Shinagawa H, Kameda R, Aoyama N, Izumi T.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):E871-8. PubMed ID: 23873677
    [Abstract] [Full Text] [Related]

  • 19. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS, Hong MK, Shin DH, Kim BK, Ko YG, Choi D, Jang Y.
    JACC Cardiovasc Imaging; 2012 Nov 01; 5(11):1147-55. PubMed ID: 23153915
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of neointimal coverage of sirolimus-eluting stents--evaluation with optical coherence tomography.
    Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, Takemoto Y, Onoue K, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y.
    Circ J; 2009 Dec 01; 73(12):2300-7. PubMed ID: 19789417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.